Benzinga.com

Fluidigm Introduces Four New Integrated Fluidic Circuits for Production Genomics

Fluidigm Corporation FLDM today introduced four new integrated fluidic circuits (IFCs) designed to meet the challenges associated with production genomics. These new offerings are expected to make ...
FierceBiotech

Fluidigm's Upcoming Stem Cell Culture Chip to Speed Development, Reduce Complexity and Lower Costs

Fluidigm will provide the latest updates for its upcoming Stem Cell Culture Chip at the World Stem Cell Summit being held in Baltimore on September 21 - 23. This specialized integrated fluidic circuit ...
Business Wire

Kyoto University’s CiRA (Director, Dr. Yamanaka) Purchases Fluidigm BioMark™ System for Stem Cell Reprogramming Research

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation today announced that the Center for iPS Cell Research and Application (CiRA; Director Dr. Shinya Yamanaka) of Kyoto University’s ...
EurekAlert!

An Integrated Fluidic Circuit for the Fluidigm C1 System (IMAGE)

This image shows the integrated fluidic circuit for the Fluidigm C1 system. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing ...
Business Wire

Fluidigm Launches Low-Cost Assays for Gene Expression, SNP Genotyping and Target-Specific Primers for Next-Generation Sequencing

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced the availability of assays and primers optimized for the company’s integrated fluidic circuit ...
Nasdaq

Fluidigm Corporation (FLDM) Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell

Fluidigm ("FLUID-DIME") Corporation (FLDM) will visit the NASDAQ MarketSite in New York City's Times Square to celebrate the company's initial public offering on The NASDAQ Stock Market. Fluidigm ...
VentureBeat

Fluidigm, maker of devices to improve life science research, files for IPO

Fluidigm, a company that makes integrated fluidic circuit systems, which make life science research easier by allowing researches to perform thousands of biochemical measurements, has filed for an ...
GEN

Oncomed to Exploit Fluidigm’s Microfluidic Devices in Cancer Stem Cell Research

Collaboration will perform gene-expression analysis of tumors and evaluate changes in cancer stem cells when mAbs are used. OncoMed Pharmaceuticals is tapping Fluidigm’s microfluidic tools for the ...
Nasdaq

GnomeDX Files for FDA Emergency Use Authorization for Rapid Turnaround Real-Time RT-PCR COVID-19 Test Utilizing the Fluidigm Biomark HD Platform

SOUTH SAN FRANCISCO, Calif., and COLUMBUS, Ohio, July 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through ...
PE Hub

Fluidigm Files for IPO

Fluidigm Corp., a South San Francisco-based provider of integrated fluidic circuits for the life sciences market, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker ...
The Motley Fool

Is This Market Correction the Right Time to Buy Fluidigm?

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...